WinstonWınston
Back
InnoCare Optoelectronics Corporation logo

InnoCare Optoelectronics Corporation

6861.TW
63
Medical - Devices · Healthcare
Price
NT$187.00
-9.50 (-4.83%)
Market Cap
NT$7.78B
Exchange
Taiwan Stock Exchange
Winston Score
63
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Good
Growth
Strong
Cash Flow
Strong
Stability
Exceptional
Valuation
Mixed
Dividends
Weak

Share count rising — dilution

+15.0% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 36.1M (2021) → 41.5M (2025)

Winston Score History

The full picture

InnoCare Optoelectronics Corporation is a Taiwan-based company that makes optoelectronic components and medical devices. Optoelectronics means products that use light and electronics together — think sensors, LEDs, and optical modules used in medical equipment, industrial machines, and consumer electronics. The company supplies components to device manufacturers and healthcare equipment makers across Asia and beyond.

InnoCare earns money primarily by selling hardware components and finished devices to business customers, not directly to consumers. It operates mainly out of Taiwan, with sales reaching markets in Asia, Europe, and North America. Its competitive position comes from specialized manufacturing know-how in optical technology, which takes time and investment for rivals to replicate. With a gross margin around 25% and an operating margin near 9%, the business is profitable but not exceptionally wide-moat. The key growth driver is rising demand for optical sensors in medical diagnostics and wearable health monitoring devices, while the main risk is customer concentration and intense price competition from other Asian component makers.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+37.4% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

+201.3% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

NT$219M/ year

Declining (-20% vs prior year)

9.5% of revenue

Below sector average (18%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

53.0%ownership

Insiders own a meaningful stake in the company

Cash Position

Cash flow positive

NT$961M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Revenue accelerating

InnoCare Optoelectronics Corporation grew revenue 37% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
28.5%
Modest — 28.5% gross margin
Profit after running costs
Operating Margin
12.6%
Healthy — 12.6% operating margin
Return on the money invested
ROCE
15.1%
Strong — 15.1% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+30.6%
Fast-growing sales (+30.6% YoY)
Profit growth
EPS YoY
+83.1%
Earnings growing fast (+83.1% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
105%
Turns 105% of profit into real cash
Spare cash per sale
FCF Margin
9.2%
Modest free cash flow (9.2%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.05
Conservative — low debt load (0.05)
Covers its interest
Interest Cover
173.38x
Comfortably covers interest (173.4x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
28.9x
Growth-priced — P/E 28.9

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year
P/E vs Forward
-8.1
SLOWING
Earnings expected to fall — forward P/E higher than today

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
0.97%
Small dividend — 0.97% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial